Sabina Frljak

Ljubljana, Slovenia

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 29 publications

Management of Tacrolimus-induced thrombotic microangiopathy in a heart transplant recipient: Utilizing novel immunosuppression strategies.

Management of Tacrolimus-induced thrombotic microangiopathy in a heart transplant recipient: Utilizing novel immunosuppression strategies.

Journal: JHLT open
Published: June 15, 2026

Case report: decommissioning of a left ventricular assist device following reverse remodeling in non-ischemic cardiomyopathy patient.

Case report: decommissioning of a left ventricular assist device following reverse remodeling in non-ischemic cardiomyopathy patient.

Journal: Journal of cardiothoracic surgery
Published: March 29, 2026

Vericiguat Therapy Is Associated with Reverse Myocardial Remodeling in Chronic Heart Failure with Reduced Ejection Fraction.

Vericiguat Therapy Is Associated with Reverse Myocardial Remodeling in Chronic Heart Failure with Reduced Ejection Fraction.

Journal: Journal of cardiovascular development and disease
Published: December 04, 2025

SGLT2 Inhibitors Are Associated with Left Ventricular Reverse Remodeling in Patients with Non-Compaction Cardiomyopathy-A Prospective Observational Cohort Trial.

SGLT2 Inhibitors Are Associated with Left Ventricular Reverse Remodeling in Patients with Non-Compaction Cardiomyopathy-A Prospective Observational Cohort Trial.

Journal: Biomedicines
Published: September 17, 2025

Renal Response to Levosimendan in Advanced Chronic Heart Failure Patients Listed for Heart Transplantation Predicts Early Postoperative Renal Function Course.

Renal Response to Levosimendan in Advanced Chronic Heart Failure Patients Listed for Heart Transplantation Predicts Early Postoperative Renal Function Course.

Journal: Journal of cardiovascular development and disease
Published: June 30, 2025

Mesenchymal stromal cells to treat patients with non-ischaemic heart failure: Results from SCIENCE II pilot study.

Mesenchymal stromal cells to treat patients with non-ischaemic heart failure: Results from SCIENCE II pilot study.

Journal: ESC heart failure
Published: March 17, 2024

Effect of allogeneic adipose tissue-derived mesenchymal stromal cell treatment in chronic ischaemic heart failure with reduced ejection fraction - the SCIENCE trial.

Effect of allogeneic adipose tissue-derived mesenchymal stromal cell treatment in chronic ischaemic heart failure with reduced ejection fraction - the SCIENCE trial.

Journal: European journal of heart failure
Published: July 24, 2022

Transendocardial CD34+ Cell Therapy Improves Local Mechanical Dyssynchrony in Patients With Nonischemic Dilated Cardiomyopathy.

Transendocardial CD34+ Cell Therapy Improves Local Mechanical Dyssynchrony in Patients With Nonischemic Dilated Cardiomyopathy.

Journal: Cell transplantation
Published: March 23, 2022

A pilot clinical trial of cell therapy in heart failure with preserved ejection fraction.

A pilot clinical trial of cell therapy in heart failure with preserved ejection fraction.

Journal: European journal of heart failure
Published: February 15, 2022

Cell Therapy in Heart Failure with Preserved Ejection Fraction.

Cell Therapy in Heart Failure with Preserved Ejection Fraction.

Journal: Cardiac failure review
Published: August 24, 2021

Efficacy and Mode of Action of Mesenchymal Stem Cells in Non-Ischemic Dilated Cardiomyopathy: A Systematic Review.

Efficacy and Mode of Action of Mesenchymal Stem Cells in Non-Ischemic Dilated Cardiomyopathy: A Systematic Review.

Journal: Biomedicines
Published: November 11, 2020

Stem Cell Therapy for Chronic and Advanced Heart Failure.

Stem Cell Therapy for Chronic and Advanced Heart Failure.

Journal: Current heart failure reports
Published: August 13, 2020
Showing 1-12 of 29

Last Updated: 09/26/2026